ENTITY
China Traditional Chinese Medicine

China Traditional Chinese Medicine (570 HK)

249
Analysis
Health CareHong Kong
China Traditional Chinese Medicine Co. Limited, through its subsidiaries, manufactures and sells medicine and pharmaceutical products in China.
more
bullishJSR Corp
06 Apr 2024 15:00

(Mostly) Asia-Pac M&A: Austal, Best World, Isetan Singapore, Langham Hospitality, Azure, Genex Power

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
475 Views
Share
02 Apr 2024 13:38

Sciclone Pharmaceuticals (6600.HK) - The Privatization Offers a Good Exit Opportunity

The success rate of privatization could be 70-80%. The time could be about six months. The annualized rate of return isn't attractive.It's up to...

Logo
376 Views
Share
bullishJSR Corp
02 Apr 2024 07:00

(Mostly) Asia M&A, Mar 2024: Chilled & Frozen, TDCX, MMA Offshore, JSR, Roland DG, SciClone

For the month of March, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$4bn. The average premium for the new deals...

Logo
360 Views
Share
01 Apr 2024 00:31

Merger Arb Mondays (01 Apr) - SciClone, IntelliCentrics, CIMC Vehicles, Lawson, Roland DG, MMA

This week, the highest gross spreads are SciClone (17.2%), Qantm IP (15.0%), Genex Power (12.2%), Southern Cross (11.2%), China TCM (7.5%), QV...

Logo
410 Views
Share
bullishLawson Inc
30 Mar 2024 15:00

(Mostly) Asia-Pac M&A:MMA, Boral, Orecorp, Probiotec, CPMC, CIMC Vehicle, Roland DG, Welbe, SciClone

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
551 Views
Share
x